Improved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting

Dinesh K. Deelchand, Kejal M Kantarci, Gülin Öz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: To investigate the utility of an advanced magnetic resonance spectroscopy (MRS) protocol in the clinical setting, and to compare the localization accuracy, spectral quality, and quantification repeatability between this advanced and the conventional vendor-provided MRS protocol on a clinical 3T platform. Methods: Proton spectra were measured from the posterior cingulate cortices in 30 healthy elderly subjects by clinical MR technologists using a vendor-provided (point resolved spectroscopy with advanced 3D gradient-echo B0 shimming) and an advanced (semi-LASER with FAST(EST)MAP shimming) protocol, in random order. Spectra were quantified with LCModel using standard pipelines for the clinical and research settings, respectively. Results: The advanced protocol outperformed the vendor-provided protocol in localization accuracy (chemical-shift-displacement error: 2.0%/ppm, semi-LASER versus 11.6%/ppm, point resolved spectroscopy), spectral quality (water linewidth: 6.1±1.8Hz, FAST(EST)MAP versus 10.5±3.7Hz, 3D gradient echo; P<7e-6; residual water: 0.08±0.12%, VAPOR versus 0.45±0.50%, WET; P<2e-5) and within-session repeatability of metabolite concentrations, particularly of low signal-to-noise ratio data with two to eight averages (test-retest coefficients of variance of metabolite concentrations, P<0.01). Concentrations of J-coupled metabolites such as γ-aminobutyric acid and glutamate were biased when using the default pipeline with simulated macromolecules. Conclusions: The quality of MRS data can be improved using advanced acquisition and analysis protocols on standard 3T hardware in the clinical setting, which can facilitate robust applications in central nervous system diseases. Magn Reson Med, 2017.

Original languageEnglish (US)
JournalMagnetic Resonance in Medicine
DOIs
StateAccepted/In press - 2017

Fingerprint

Magnetic Resonance Spectroscopy
Spectrum Analysis
Aminobutyrates
Water Quality
Central Nervous System Diseases
Gyrus Cinguli
Signal-To-Noise Ratio
Clinical Protocols
Protons
Glutamic Acid
Healthy Volunteers
Water
Research
MAP protocol

Keywords

  • 3T
  • Chemical shift displacement
  • FAST(EST)MAP
  • Linewidth
  • PRESS
  • SLASER

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

@article{38596c5e6ae5473db748dce3db507685,
title = "Improved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting",
abstract = "Purpose: To investigate the utility of an advanced magnetic resonance spectroscopy (MRS) protocol in the clinical setting, and to compare the localization accuracy, spectral quality, and quantification repeatability between this advanced and the conventional vendor-provided MRS protocol on a clinical 3T platform. Methods: Proton spectra were measured from the posterior cingulate cortices in 30 healthy elderly subjects by clinical MR technologists using a vendor-provided (point resolved spectroscopy with advanced 3D gradient-echo B0 shimming) and an advanced (semi-LASER with FAST(EST)MAP shimming) protocol, in random order. Spectra were quantified with LCModel using standard pipelines for the clinical and research settings, respectively. Results: The advanced protocol outperformed the vendor-provided protocol in localization accuracy (chemical-shift-displacement error: 2.0{\%}/ppm, semi-LASER versus 11.6{\%}/ppm, point resolved spectroscopy), spectral quality (water linewidth: 6.1±1.8Hz, FAST(EST)MAP versus 10.5±3.7Hz, 3D gradient echo; P<7e-6; residual water: 0.08±0.12{\%}, VAPOR versus 0.45±0.50{\%}, WET; P<2e-5) and within-session repeatability of metabolite concentrations, particularly of low signal-to-noise ratio data with two to eight averages (test-retest coefficients of variance of metabolite concentrations, P<0.01). Concentrations of J-coupled metabolites such as γ-aminobutyric acid and glutamate were biased when using the default pipeline with simulated macromolecules. Conclusions: The quality of MRS data can be improved using advanced acquisition and analysis protocols on standard 3T hardware in the clinical setting, which can facilitate robust applications in central nervous system diseases. Magn Reson Med, 2017.",
keywords = "3T, Chemical shift displacement, FAST(EST)MAP, Linewidth, PRESS, SLASER",
author = "Deelchand, {Dinesh K.} and Kantarci, {Kejal M} and G{\"u}lin {\"O}z",
year = "2017",
doi = "10.1002/mrm.26788",
language = "English (US)",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Improved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting

AU - Deelchand, Dinesh K.

AU - Kantarci, Kejal M

AU - Öz, Gülin

PY - 2017

Y1 - 2017

N2 - Purpose: To investigate the utility of an advanced magnetic resonance spectroscopy (MRS) protocol in the clinical setting, and to compare the localization accuracy, spectral quality, and quantification repeatability between this advanced and the conventional vendor-provided MRS protocol on a clinical 3T platform. Methods: Proton spectra were measured from the posterior cingulate cortices in 30 healthy elderly subjects by clinical MR technologists using a vendor-provided (point resolved spectroscopy with advanced 3D gradient-echo B0 shimming) and an advanced (semi-LASER with FAST(EST)MAP shimming) protocol, in random order. Spectra were quantified with LCModel using standard pipelines for the clinical and research settings, respectively. Results: The advanced protocol outperformed the vendor-provided protocol in localization accuracy (chemical-shift-displacement error: 2.0%/ppm, semi-LASER versus 11.6%/ppm, point resolved spectroscopy), spectral quality (water linewidth: 6.1±1.8Hz, FAST(EST)MAP versus 10.5±3.7Hz, 3D gradient echo; P<7e-6; residual water: 0.08±0.12%, VAPOR versus 0.45±0.50%, WET; P<2e-5) and within-session repeatability of metabolite concentrations, particularly of low signal-to-noise ratio data with two to eight averages (test-retest coefficients of variance of metabolite concentrations, P<0.01). Concentrations of J-coupled metabolites such as γ-aminobutyric acid and glutamate were biased when using the default pipeline with simulated macromolecules. Conclusions: The quality of MRS data can be improved using advanced acquisition and analysis protocols on standard 3T hardware in the clinical setting, which can facilitate robust applications in central nervous system diseases. Magn Reson Med, 2017.

AB - Purpose: To investigate the utility of an advanced magnetic resonance spectroscopy (MRS) protocol in the clinical setting, and to compare the localization accuracy, spectral quality, and quantification repeatability between this advanced and the conventional vendor-provided MRS protocol on a clinical 3T platform. Methods: Proton spectra were measured from the posterior cingulate cortices in 30 healthy elderly subjects by clinical MR technologists using a vendor-provided (point resolved spectroscopy with advanced 3D gradient-echo B0 shimming) and an advanced (semi-LASER with FAST(EST)MAP shimming) protocol, in random order. Spectra were quantified with LCModel using standard pipelines for the clinical and research settings, respectively. Results: The advanced protocol outperformed the vendor-provided protocol in localization accuracy (chemical-shift-displacement error: 2.0%/ppm, semi-LASER versus 11.6%/ppm, point resolved spectroscopy), spectral quality (water linewidth: 6.1±1.8Hz, FAST(EST)MAP versus 10.5±3.7Hz, 3D gradient echo; P<7e-6; residual water: 0.08±0.12%, VAPOR versus 0.45±0.50%, WET; P<2e-5) and within-session repeatability of metabolite concentrations, particularly of low signal-to-noise ratio data with two to eight averages (test-retest coefficients of variance of metabolite concentrations, P<0.01). Concentrations of J-coupled metabolites such as γ-aminobutyric acid and glutamate were biased when using the default pipeline with simulated macromolecules. Conclusions: The quality of MRS data can be improved using advanced acquisition and analysis protocols on standard 3T hardware in the clinical setting, which can facilitate robust applications in central nervous system diseases. Magn Reson Med, 2017.

KW - 3T

KW - Chemical shift displacement

KW - FAST(EST)MAP

KW - Linewidth

KW - PRESS

KW - SLASER

UR - http://www.scopus.com/inward/record.url?scp=85020734235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020734235&partnerID=8YFLogxK

U2 - 10.1002/mrm.26788

DO - 10.1002/mrm.26788

M3 - Article

C2 - 28618085

AN - SCOPUS:85020734235

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

ER -